Roche and CuraGen have announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in ...
CuraGen Corporation's majority-owned subsidiary 454 Life Sciences has announced that research on small RNAs, conducted by Cold Spring Harbor Laboratory, has revealed the dual role of the ARGONAUTE 4 ...
High-throughput, next-generation sequencing instruments have dramatically accelerated the sequencing of genomes. The growth of this technology serves as an important milepost for the biomedical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback